Witten
Germany
21
2025-06-19
3
2018-01-16
These are the the leading inventors for applications assigned to Bitop AG:
Bitop AG based in Witten, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMPOSITION FOR TREATING THE EYE
#2 | 2022-05-05Composition for Treating the Eye
#3 | 2021-07-15COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE
#4 | 2021-05-20METHOD FOR ENHANCING CONTINUOUS PRODUCTION OF A NATURAL COMPOUND DURING EXPONENTIAL GROWTH PHASE AND STATIONARY PHASE OF A MICROORGANISM
#5 | 2019-12-19Composition Containing N-acetyldiaminobutyric Acid
#6 | 2019-11-21COMPOSITION FOR CONTROLLING GASTROESOPHAGEAL REFLUX DISEASES
#7 | 2019-04-25COMPOSITION FOR STIMULATING SIRTUIN ACTIVITY
#8 | 2018-12-13COMPATIBLE SOLUTE OR SOLUTE MIXTURE FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES HAVING BARRIER DEFECTS IN EPITHELIAL TISSUES
#9 | 2018-01-18USE OF GLUCOSYLGLYCEROL
#10 | 2017-07-20OSMOLYTE-CONTAINING PREPARATION FOR THE TREATMENT OF DRY MUCOUS MEMBRANES
#11 | 2017-07-06COMPOSITION CONTAINING ECTOINE OR HYDROXYECTOINE AS AN ACTIVE SUBSTANCE FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE
#12 | 2017-06-22Composition for Treating the Eye
#13 | 2016-04-21TREATING POSTOPERATIVE MECHANICAL STRESS WITH AN ECTOINE
#14 | 2015-11-12OSMOLYTE-CONTAINING PREPARATION FOR THE TREATMENT OF DRY MUCOUS MEMBRANES
#15 | 2015-04-16ORGAN STORAGE SOLUTION
#16 | 2013-04-04OSMOLYTE-CONTAINING PREPARATION FOR THE TREATMENT OF DRY MUCOUS MEMBRANES
#17 | 2011-08-25 ✅ Patent 9,867,767 granted on 2018-01-16Use of glucosylglycerol
#18 | 2010-11-25OSMOLYTE-CONTAINING PREPARATION FOR USE IN CASE OF DRY MUCOUS MEMBRANES
#19 | 2009-03-12UTILIZATION OF COMPATIBLE SOLUTES TO IMPROVE THE PERFORMANCE OF THE TECHNIQUES USING IMMOBILIZED BIOLOGIC MATERIALS
#20 | 2009-03-05 ✅ Patent 9,089,568 granted on 2015-07-28Method of using compatible solutes containing ectoine and/or hydroxyectoine
#21 | 2006-12-12 ✅ Patent 7,147,849 granted on 2006-12-12Pharmaceutical formulation
16925 ⎘